Cantitate/Preț
Produs

Male Breast Cancer

Autor Ian Fentiman
en Limba Engleză Hardback – 8 mar 2017
This book provides an up-to-date review of the risk factors and genetics influencing the development of this rare disease. This volume presents clinical features and recent advances in histopathology and molecular profiling are analyzed, providing a valuable aid to clinicians in tailoring treatment to both the patient and the tumour. Readers will find important insights into the most effective strategies for making or negating a diagnosis of MBC. Within this timely volume, consideration is also given to the psychological needs of men with breast cancer alongside a discussion of the most effective support methods. The surgical management of the disease is examined, together with algorithms for local and systemic therapy. Owing to the problem of late diagnosis in MBC, many men have advanced or disseminated disease at diagnosis and, as such, the evidence-based management of these cases is reviewed. Male Breast Cancer concludes with a discussion on determiningprognosis and the likely future developments in MBC with a focus on improved diagnosis and survival. Male Breast Cancer will be of interest to breast surgeons, oncologists, breast radiologists, breast histopathologists and breast care nurses worldwide.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 89107 lei  38-44 zile
  Springer International Publishing – 3 mai 2018 89107 lei  38-44 zile
Hardback (1) 93453 lei  38-44 zile
  Springer International Publishing – 8 mar 2017 93453 lei  38-44 zile

Preț: 93453 lei

Preț vechi: 98371 lei
-5% Nou

Puncte Express: 1402

Preț estimativ în valută:
17896 19367$ 14919£

Carte tipărită la comandă

Livrare economică 05-11 decembrie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783319046686
ISBN-10: 3319046683
Pagini: 200
Ilustrații: X, 173 p. 5 illus., 3 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.96 kg
Ediția:1st ed. 2017
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland

Public țintă

Professional/practitioner

Cuprins

Risk factors.- Genetics.- Clinical features.- Histopathology.- Molecular profile.- Diagnosis.- Psychosocial.- Surgical treatment.- Adjuvant treatment.- Treatment of advanced disease.- Prognosis.- The future.

Notă biografică

Consultant Surgeon, Guy's Hospital, London 1982 Professor of Surgical Oncology, Guy's Hospital, London 1996 Awards Arris and Gale Lecturer Royal College of Surgeons of England 1978 Keith Durrant Memorial Lecture British Oncological Association 1991 Honoured by Cancer Care for advancing treatment of early breast cancer as one of the 100 Investigators published most frequently in the 20th century. San Antonio December 2000.

Textul de pe ultima copertă

This book provides an up-to-date review of the risk factors and genetics influencing the development of this rare disease. This volume presents clinical features and recent advances in histopathology and molecular profiling are analysed, providing a valuable aid to clinicians in tailoring treatment to both the patient and the tumour.
Readers will find important insights into the most effective strategies for making or negating a diagnosis of male breast cancer. Within this timely volume, consideration is also given to the psychological needs of men with breast cancer alongside a discussion of the most effective support methods.
The surgical management of the disease is examined, together with algorithms for local and systemic therapy. Owing to the problem of late diagnosis in male breast cancer, many men have advanced or disseminated disease at diagnosis and, as such, the evidence-based management of these cases is reviewed. 
This book will be of interest to breast surgeons, oncologists, breast radiologists, breast histopathologists and breast care nurses worldwide.

Caracteristici

Provides a comprehensive and authoritative overview of the diagnosis and treatment of a rare disease Data are summarised in tables, providing enhanced clarity Offers an up-to-date resource of available data allowing for evidence-based decision making